Christine Ocampo Net Worth & Insider Trades
Christine Ocampo - See Remarks, Novus Therapeutics, Inc
What is Christine Ocampo's Net Worth?
The current estimated net worth of Novus Therapeutics, Inc's See Remarks, Christine Ocampo, is estimated to be about $215.68K . Christine Ocampo owns about 21,590 units of Novus Therapeutics, Inc common stock. In the last month at Novus Therapeutics, Inc, Christine Ocampo has sold an estimated value of $0 worth.
What is Christine Ocampo's Past Insider Trading?
Christine Ocampo's largest purchase order was 10,010 units , worth over $100K on May 11, 2017. In total, Christine Ocampo has made about 2 transactions over a month of their time at Novus Therapeutics, Inc. Christine Ocampo usually trades in May, with the busiest year in 2017.
Christine Ocampo
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Christine Ocampo's' Mailing Address?
- Mailing address is C/o Urovant Sciences, Inc. 5281 California Avenue, Suite 100 Irvine CA 92617 CA
What are Novus Therapeutics, Inc's Past Insider Trades?
Novus Therapeutics, Inc's most recent insider trade came on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed who sold 103,200 units worth $2.23M . In the last 3 years, insiders at Novus Therapeutics, Inc have sold an estimated value of $2.63M and bought an estimated value of $7.31M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Catherine C Turkel, President, Gregory J Flesher, Chief Executive Officer, and Jon Kuwahara, See Remarks .
Eledon Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |